| Freda D. Miller | |
| Workplaces: | University of Toronto, Hospital for Sick Children |
| Known For: | Developmental Neurobiology |
| Awards: | Fellow, Royal Society of Canada, Fellow, American Association for the Advancement of Science (AAAS), Howard Hughes Medical Institute International Research Scholar |
| Website: | https://lab.research.sickkids.ca/miller-kaplan/principal-investigators/ |
| Alma Mater: | University of Saskatchewan, University of Calgary |
Dr. Freda Miller, FRSC is a developmental neurobiologist at the Hospital for Sick Children Research Institute and a professor at the University of Toronto. Dr. Miller holds a Canada Research Chair in developmental neurobiology and her work focuses on development and regeneration of neurons.[1] [2]
Dr. Miller spent some of her early years in Calgary and attended the gifted program at Queen Elizabeth High School in Calgary.[3] She received a Ph.D. degree in medical sciences at the University of Calgary and earned her B.Sc. degree in biochemistry at the University of Saskatchewan.[2]
In 2002, Miller was a founder of the Canadian biotech company Aegera Therapeutics.
In recognition of Dr. Freda Miller's scientific career, trustees of the Calgary Board of Education named a new elementary school "Dr. Freda Miller School". The school opened in September 2020.[6]
Dr. Freda Miller works on neuronal repair mechanism and has published over 140 articles on different areas of the nervous system, including skin stem cells, neuronal growth, survival and death.[7] [8] Miller also has 15 issued and pending patents.[9]
Her research interests include: